Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders.
about
Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporterHepatocyte and Sertoli Cell Aquaporins, Recent Advances and Research TrendsNew insights in bilirubin metabolism and their clinical implicationsClinical application of transcriptional activators of bile salt transporters.Bile formation and secretion.INTRACELLULAR SIGNALING BY BILE ACIDS.Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogenNew perspectives for the treatment of cholestasis: lessons from basic science applied clinically.Biology of a novel organic solute and steroid transporter, OSTalpha-OSTbeta.Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.Characterization of hepatic-organoid cultures.Chemiluminescence quantitative immunohistochemical determination of MRP2 in liver biopsies.Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis.Adenoviral transfer of human aquaporin-1 gene to rat liver improves bile flow in estrogen-induced cholestasis.Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter.Loss of A(1) adenosine receptor attenuates alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice.Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice.Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis.LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process.Protective effects of salep against isoniazid liver toxicity in wistar rats.Intestinal injury in the rat model of 17α-ethynylestradiol-induced intrahepatic cholestasis.Effect of YHHJ on the expression of the hepatocellular bile acid transporters multidrug resistance-associated protein 2 and bile salt export pump in ethinylestradiol-induced cholestasis.
P2860
Q24534978-934FDBE5-AF86-4194-B947-25D4CB245EB8Q26740558-220D645C-FA5D-47C2-B5BB-3C35B0145BFCQ26863145-B6EC5D67-38D7-4CB4-BB04-060D8099DC40Q33709930-52BD913D-F918-4705-92BD-028ED5802F5AQ33881922-92ABC76E-A7AC-41FA-B97F-A0EB29C4D40FQ34448448-D9F7F7A4-0DA4-48F0-AE2F-2F9337E8F717Q34990717-609853C5-F9F2-4A52-B254-6666BFC9BCDEQ35597096-36934F04-6790-4CBD-94BE-454EFD0945BEQ35741546-70AA67E3-BCCE-41AE-B401-9FE45B43C9D6Q36295902-BCE686A0-F659-42B9-89EB-6B24BD3ABED5Q36606886-3221B17E-4143-4419-8885-331CDAB2B3CCQ37660405-2D2E0CE3-A892-4484-97A8-F373B571A785Q38317938-AB20DA3A-9996-46B2-B30D-A02E8F969665Q41647064-9B7F5EDB-977B-4D56-8860-69827DFEAFC1Q42190209-313692EE-4E6E-4C76-BB52-D0D68C8FAD70Q42511033-53594579-6CE4-48D8-8711-F3C8B65EDC94Q42716029-48ABAA4A-E387-42FD-8720-4F32A5D1E9EDQ43829156-BFDCBB95-6E8A-45D4-8CB1-8AF249A7A455Q44277493-EB9A84C8-3E07-44E7-B05B-4D60F1BFEB67Q46453388-73C09E12-EB54-4E42-9F1D-460256AA38FBQ47325093-F33F1389-7F24-46AA-A3D4-E97911BEE1ABQ49872508-8F18AAF0-7E03-4DAD-A05A-94D9B9013F34Q51510908-FD5A4377-554D-41FD-97CF-66464EAE7617Q55248620-EE7692E0-A450-4A88-B285-578756D89586
P2860
Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular alterations in hepat ...... d cholestatic liver disorders.
@ast
Molecular alterations in hepat ...... d cholestatic liver disorders.
@en
Molecular alterations in hepat ...... d cholestatic liver disorders.
@nl
type
label
Molecular alterations in hepat ...... d cholestatic liver disorders.
@ast
Molecular alterations in hepat ...... d cholestatic liver disorders.
@en
Molecular alterations in hepat ...... d cholestatic liver disorders.
@nl
prefLabel
Molecular alterations in hepat ...... d cholestatic liver disorders.
@ast
Molecular alterations in hepat ...... d cholestatic liver disorders.
@en
Molecular alterations in hepat ...... d cholestatic liver disorders.
@nl
P356
P1476
Molecular alterations in hepat ...... d cholestatic liver disorders.
@en
P304
P356
10.1055/S-2000-9390
P577
2000-01-01T00:00:00Z